PATENT CLAIM ANALYSIS

Application Number: 16182845
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-07
Patent Classification: ["514", "063000"]

Abstract:
Compounds that have agonist activity at one or more of the S1P receptors are provided. The compounds are sphingosine analogs that, after phosphorylation, can behave as agonists at S1P receptors.

Claim (Index 117):
The method of  claim 113 , further comprising administering to said mammal an effective amount of one or more drugs selected from the group consisting of: a corticosteroid, a bronchodilator, an antiasthmatic, an antiinflammatory, an antirheumatic, an immunosuppressant, an antimetabolite, an immunomodulator, an antipsoriatic, and an antidiabetic.

Metadata:
- Claim Count in Document: 43.0
- Percentile: 98.0
- Lexical Diversity: 1.25926
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15783809', '15397421', '13389054', '14306231', '14874600']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8489153535320729
- 35 USC 102 Novelty (BERT): 0.5934136432389733
- Combined Prediction Score: 0.823365182502763
- Mean Citation Score: 540.187412
- Max Citation Score: 542.35815
- Similarity Product: 464.96832047127486

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test